CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Nettle and Cranberry complex capsules +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05880602
NCT05880602N/ACompleted

Clinical Trial of Nettle and Cranberry Capsules for Prevention of Urinary Tract Infection

Chung Shan Medical University·interventional·Posted May 30, 2023·Updated Sep 26, 2025

In Brief

A clinical study evaluating Nettle and Cranberry complex capsules and Placebo(starch) for Urinary Tract Infection. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This study investigates whether the oral intake of a nettle and cranberry complex capsule may prevent recurrent urinary tract infection (rUTI). Participants will be aged between 30 - 75 years of age, with confirmed diagnosis of UTI status. The participants will be assessed for several parameters and asked to take 2 nettle and cranberry complex capsules twice daily for 8 weeks. The parameters will include international prostate symptoms score (IPSS), overactive bladder symptom score (OABSS), international consultation on incontinence questionnaire - overactive bladder (ICIQ-OAB), 3-day bladder diary (3dBD), and urine routine.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTaiwan

Timeline

N/ACompletedFinished
202420252026
First PostedMay 30, 2023
Enrollment StartJul 5, 2023
Primary CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 3.1 years ago

Interventions

Nettle and Cranberry complex capsulesdietary

A specific capsule product, containing nettle and cranberry complex will be given to participants for oral intake for 8 weeks.

Placebo(starch)dietary

A specific capsule product, containing starch will be given to participants for oral intake for 8 weeks.